GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » Cyclically Adjusted FCF per Share

Universal Vision Biotechnology Co (ROCO:3218) Cyclically Adjusted FCF per Share : NT$4.25 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Universal Vision Biotechnology Co's adjusted free cash flow per share for the three months ended in Dec. 2023 was NT$4.143. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$4.25 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Universal Vision Biotechnology Co's average Cyclically Adjusted FCF Growth Rate was 40.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 59.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Universal Vision Biotechnology Co was 59.90% per year. The lowest was 59.90% per year. And the median was 59.90% per year.

As of today (2024-06-22), Universal Vision Biotechnology Co's current stock price is NT$249.00. Universal Vision Biotechnology Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was NT$4.25. Universal Vision Biotechnology Co's Cyclically Adjusted Price-to-FCF of today is 58.59.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Universal Vision Biotechnology Co was 355.80. The lowest was 56.47. And the median was 117.59.


Universal Vision Biotechnology Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Universal Vision Biotechnology Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co Cyclically Adjusted FCF per Share Chart

Universal Vision Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 1.04 1.76 3.02 4.25

Universal Vision Biotechnology Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.02 3.55 3.72 3.89 4.25

Competitive Comparison of Universal Vision Biotechnology Co's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Universal Vision Biotechnology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Vision Biotechnology Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Vision Biotechnology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Universal Vision Biotechnology Co's Cyclically Adjusted Price-to-FCF falls into.



Universal Vision Biotechnology Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Universal Vision Biotechnology Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=4.143/129.4194*129.4194
=4.143

Current CPI (Dec. 2023) = 129.4194.

Universal Vision Biotechnology Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.364 99.695 -0.473
201406 -0.084 100.560 -0.108
201409 0.782 100.428 1.008
201412 0.028 99.070 0.037
201503 -0.223 99.621 -0.290
201506 0.053 100.684 0.068
201509 -0.787 100.392 -1.015
201512 -0.392 99.792 -0.508
201603 0.530 100.470 0.683
201606 -0.150 101.688 -0.191
201609 0.044 101.861 0.056
201612 0.663 101.863 0.842
201703 0.212 102.862 0.267
201706 0.410 103.349 0.513
201709 0.378 104.136 0.470
201712 0.237 104.011 0.295
201803 -0.315 105.290 -0.387
201806 0.441 106.317 0.537
201809 -0.075 106.507 -0.091
201812 0.730 105.998 0.891
201903 0.714 107.251 0.862
201906 -0.079 108.070 -0.095
201909 1.035 108.329 1.236
201912 0.452 108.420 0.540
202003 1.622 108.902 1.928
202006 1.201 108.767 1.429
202009 1.412 109.815 1.664
202012 1.990 109.897 2.344
202103 0.830 111.754 0.961
202106 0.384 114.631 0.434
202109 2.497 115.734 2.792
202112 3.160 117.630 3.477
202203 3.123 121.301 3.332
202206 0.933 125.017 0.966
202209 2.228 125.227 2.303
202212 2.851 125.222 2.947
202303 4.421 127.348 4.493
202306 1.916 128.729 1.926
202309 2.236 129.860 2.228
202312 4.143 129.419 4.143

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Universal Vision Biotechnology Co  (ROCO:3218) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Universal Vision Biotechnology Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=249.00/4.25
=58.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Universal Vision Biotechnology Co was 355.80. The lowest was 56.47. And the median was 117.59.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Universal Vision Biotechnology Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Vision Biotechnology Co (ROCO:3218) Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115
Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co (ROCO:3218) Headlines

No Headlines